Protalix BioTherapeutics, Inc. (PLX)

Protalix BioTherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	27.41	23.63	17.11	38.99	18.27	17.79
Short-Term Investments	-	20.93	5.07	-	20.28	-
Cash & Short-Term Investments	27.41	44.56	22.18	38.99	38.55	17.79
Cash Growth	-33.11%	100.90%	-43.11%	1.14%	116.64%	-52.94%
Accounts Receivable	2.2	5.27	4.59	3.44	2	4.7
Other Receivables	-	0.48	0.36	0.31	0.77	0.63
Receivables	2.2	5.75	4.95	3.75	2.77	5.33
Inventory	17.2	19.05	16.8	17.95	13.08	8.16
Prepaid Expenses	-	0.44	0.77	0.91	0.84	0.31
Other Current Assets	1.05	0.13	0.17	0.07	0.48	0.89
Total Current Assets	47.85	69.93	44.88	61.67	55.72	32.48
Property, Plant & Equipment	10.29	10.88	9.64	9.92	10.41	10.95
Long-Term Deferred Tax Assets	2.86	3.09	-	-	-	-
Other Long-Term Assets	0.56	0.53	1.27	2.08	1.8	1.96
Total Assets	61.56	84.43	55.79	73.67	67.93	45.39
Accounts Payable	3.14	4.32	5.86	6.99	7.22	6.5
Accrued Expenses	11.88	13.2	11.6	16.34	13.61	11.81
Current Portion of Long-Term Debt	-	20.25	-	-	58.51	4.3
Current Portion of Leases	1.51	1.41	1.12	1.21	1.42	1.14
Current Income Taxes Payable	3.04	2.88	0.53	-	-	-
Current Unearned Revenue	-	-	13.18	8.55	5.39	16.34
Other Current Liabilities	4.66	3.48	0.14	0.1	0.32	0.1
Total Current Liabilities	24.22	45.53	32.43	33.18	86.47	40.18
Long-Term Debt	-	-	28.19	27.89	-	50.96
Long-Term Leases	4.18	4.62	4.17	4.38	4.47	4.53
Long-Term Unearned Revenue	-	-	-	11.79	1.72	16.98
Other Long-Term Liabilities	-	-	-	-	0.05	0.51
Total Liabilities	29.13	50.87	66.43	79.7	94.97	115.71
Common Stock	0.07	0.07	0.05	0.05	0.04	0.02
Additional Paid-In Capital	417.25	415.05	379.17	368.85	320.28	270.49
Retained Earnings	-384.89	-381.55	-389.86	-374.93	-347.35	-340.83
Shareholders' Equity	32.44	33.57	-10.64	-6.04	-27.04	-70.32
Total Liabilities & Equity	61.56	84.43	55.79	73.67	67.93	45.39
Total Debt	5.68	26.28	33.47	33.47	64.4	60.93
Net Cash (Debt)	21.73	18.28	-11.29	5.52	-25.86	-43.13
Net Cash Per Share	0.30	0.22	-0.23	0.12	-0.89	-2.91
Filing Date Shares Outstanding	73.63	73.05	57.35	46.32	45.38	14.84
Total Common Shares Outstanding	73.63	72.95	53.79	45.56	34.77	14.84
Working Capital	23.63	24.4	12.45	28.49	-30.75	-7.7
Book Value Per Share	0.44	0.46	-0.20	-0.13	-0.78	-4.74
Tangible Book Value	32.44	33.57	-10.64	-6.04	-27.04	-70.32
Tangible Book Value Per Share	0.44	0.46	-0.20	-0.13	-0.78	-4.74
Machinery	-	22.02	21.32	20.96	20.11	19.49
Leasehold Improvements	-	17.64	16.92	16.76	16.66	16.49

Source: S&P Capital IQ. Standard template. Financial Sources.